Effects of antiresorptive treatment on nonvertebral fracture outcomes. (Q44488735)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

meta-analysis

0 references

title

Effects of antiresorptive treatment on nonvertebral fracture outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

4

Eugene V McCloskey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

Dennis M Black

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Dawn C Mackey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Douglas C Bauer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Peter Mesenbrink

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

John R Thompson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Steven R Cummings

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Research

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

2411-2418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710615%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

6 February 2020

cites work

1 reference

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

21 January 2018

1 reference

Lasofoxifene in postmenopausal women with osteoporosis

21 January 2018

1 reference

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

21 January 2018

1 reference

Cost-effective osteoporosis treatment thresholds: the United States perspective

21 January 2018

1 reference

High-trauma fractures and low bone mineral density in older women and men.

21 January 2018

1 reference

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

21 January 2018

1 reference

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

21 January 2018

1 reference

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

21 January 2018

1 reference

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

21 January 2018

1 reference

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

21 January 2018

1 reference

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

FRAX and the assessment of fracture probability in men and women from the UK

21 January 2018

1 reference